Skip to main content

Wi go tɔk bɔt di Amvuttra mɛrɛsin fɔ di at sik we dɛn kɔl ATTR-CM? (ATTR-CM & Amvuttra) ɛn di ɔda wan dɛn.

Wi go tɔk bɔt di Amvuttra mɛrɛsin fɔ di at sik we dɛn kɔl ATTR-CM? (ATTR-CM & Amvuttra) ɛn di ɔda wan dɛn.

Yu nɔr dɔn yɛri bɔt sik dɛm wae kin kam wae wan kayn prɔtin na wi bɔdi nɔr kin gɛda kɔrɛkt wan ɛn kin de na impɔtant ɔgan dɛm lɛk di at ɛn di nerv dɛm. Bɔku tɛm, dɛn sik ya na sik dɛn we nɔ kin apin so ɔltɛm. Insay mɛrɛsin, dɛn kɔl dis kayn prɔtin we de na di bɔdi amyloidosis . Tide, wi go tɔk bɔt wan sik we nɔ kin bɔku we dɛn kɔl ATTR-CM, we kin afɛkt di at spɛshal wan, dat na we dɛn prɔtin ya kin de na di at mɔsul, ɛn di mɔdan drɔg we dɛn kɔl Amvuttra we dɛn kin yuz fɔ am.

Wetin na ATTR-CM rili?

fכ simpul wan, ATTR-CM na kכndyushכn we, bikoz fכ wan jεnεtik difεkt כ we de apin nכmal wan wit ol pipul dεm, di protin TTR we de prodyuz na wi bכdi, de chenj shep εn kכlכm tכgeda εn deposit insεf na di wכl dεm na di at mכsul. Di ful nem fɔ dis na Transthyretin Amyloid Cardiomyopathy.

Tink bɔt am, wi at wɔl dɛn nid fɔ fleksibul fɔ pɔmp fayn fayn wan. Bɔt we dɛn prɔtin ya kin bɔku, di wɔl dɛn na di at kin tik ɛn stif . Wi kin kɔl dis kadiomayopathy. Dis kin mek di at nɔ ebul fɔ pɔmp blɔd fayn fayn wan. As tɛm de go, dis kin ivin go bifo te i nɔ de wok fayn.

Sɔm pipul dɛm wae gɛt ATTR-CM nɔr kin gɛt ɛni sayn, bɔt ɔda pipul dɛm kin gɛt sayn dɛm wae fiba di wan dɛm wae gɛt nɔrmal at atak.

  • Smɔl shɔt brith (dyspnea) .
  • Swel, mɔ na di leg ɛn anklɛ
  • Kɔnfyushɔn ɔ pwɛl at
  • At rit we de go ɔp ɔ at bit we nɔ de bit ɔltɛm
  • Chɛst de pen

Dis kin mek yu fil taya kwik kwik wan we yu de du tin lɛk fɔ klaym stej, fɔ du os wok, ɔ fɔ waka fɔ shɔt tɛm.

Apat frɔm dat, ɔda sayn dɛn we nɔ gɛt natin fɔ du wit di at kin apin bak. Fɔ ɛgzampul, wikɛd, swɛt ɔ pen na yu an ɛn fut, yu de swet pasmak , yu ed de tɔn ɔ yu fɔdɔm, ɛn yu gɛt prɔblɛm wit yu digest.

Aw Amvuttra mɛrɛsin de wok?

fכ כndastand dis, wi fכs nid fכ no sכm bכt wan protin we dεn kכl TTR. TTR (Transthyretin) na wan prɔtin we dɛn kin mek mɔ na wi liva. di men wok we i de du na fכ transpot di tayroyd כmon dεm εn vaytam in A כlsay na di bכdi.

pan pipul dεm we gεt ATTR-CM, wan jεnεtik difεkt de mek di TTR protin de prodyuz in kכrekt shep. dis kכrekt shep fכ di protin de kכmכt εn dכn na di at.

Di drɔg we dɛn kɔl Amvuttra de wok lɛk jin saylɛns . dat min se dis dכg de go stret na di liva εn i de blכk da fכlt TTR protin de.i de ridyus di aktiviti fכ di jin we dεn de mek. I tan lɛk we yu de tɔn di vɔlyum dɔŋ na redio.

dis de ridyus di fכlt TTR protin we di liva de prodyuz, we in tכn de ridyus di dכpos fכ nyu protin dεm na כgan dεm lεk di at.

Amvuttra na injɛkshɔn we dɛn kin put ɔnda di bɔdi. Dis vaysin na pɔsin we sabi kia fɔ wɛlbɔdi biznɛs kin gi am ɛvri tri mɔnt .

Aw dɛn bin tɛst di sakrifays we dis mɛrɛsin bin gɛt?

Lɛk ɛni nyu mɛrɛsin, dɛn dɔn kɔnfyus di ɛfɛktiv we AMVUTTRA de du tru wan big stɔdi. Insay dis stɔdi, dɛn gi 655 ATTR-CM pasɛnt dɛn di Amvuttra vaysin ɛn di ɔda grup dɛn gi wan plesibo vaysin we nɔ gɛt ɛni drɔg ɛvri 12 mɔnt fɔ tri ia.

Risach pipul dɛn bin luk bɔku tin dɛn fɔ no if dis mɛrɛsin de wok.

  • Siks minit waka tɛst: Dis de mɛzhɔ aw fa yu kin waka wit nɔmal paz insay 6 minit. Dis distans de go dɔŋ as yu at de wɔs.
  • Nyu Yɔk At Asɛmbli (NYHA) klasification: Dis de mɛzhɔ aw di sayn dɛm wae de sho se pɔrsin gɛt at pwɛl. Fo klas de (I, II, III, IV). Di mɔ di klas nɔmba de bɔku, na di mɔ di sik kin rili bad.
NYHA Klas Tɔk bɔt
Klas I No ristrikshɔn nɔ de fɔ di nɔmal tin dɛn we pɔsin kin du fɔ du in bɔdi. Nɔ taya, nɔ de blo shɔt, ɔ pen na in chɛst.
Klas II Di tin dɛn we pɔsin kin du fɔ du bɔdi wok nɔ kin izi fɔ du. Nɔbɔdi nɔ kin fil bad we yu de rɛst, bɔt yu kin taya ɛn taya we yu de du tin dɛn we yu de du nɔmal tin.
Klas IIIdi fyzikal aktiviti dεm nכ kin bכku, εn di sayn dεm kin apin ivin we i de wok tranga pas di nכmal wok.
Klas IV Di sayn dɛm kin de ivin we yu rɛst. Ɛnitin we yu de du fɔ yu bɔdi kin mek di sik wɔs.
  • Kwaliti ɔf Layf Kwɛshɔn (KCCQ-OS): Dis de mɛzhɔ di impak we di sik gɛt pan di pɔsin in kwaliti layf.

Wetin di risach bin fɛn?

We di tri ia tritmɛnt tɛm dɔn, di wan dɛn we du di risach bin analayz di rizɔlt dɛn.

Di men tin we dɛn fɛn na dat di pasɛnt dɛn we bin gɛt Amvuttra bin gɛt 28% lɔwa risk fɔ day ɔ fɔ go na ɔspitul wantɛm wantɛm ɔ fɔ go na di imejensi rum (ETU) bikɔs dɛn at pwɛl , we yu kɔmpia dɛn wit di wan dɛn we bin gɛt plasɛbo (wan dɔmi vaysin).

Wan ɔda impɔtant tin na dat we 42 mɔnt dɔn, di risk fɔ day frɔm ɛni kɔz bin ridyus bay 35% na di grup we bin gɛt Amvuttra.

Apat frɔm dat, di pasɛnt dɛn we bin gɛt Amvuttra bin gɛt wan kɔntrol dɛklin pan di ebul fɔ waka ɛn di kwaliti fɔ layf.

Bɔt mɛmba se dɛn risach ya nɔ go bi di sem fɔ ɔlman. Yu ɛn yu dɔktɔ go nid fɔ disayd togɛda if Amvuttra rayt fɔ yu ɛn if di bɛnifit dɛn pas di sayd ɛfɛkt dɛn.

Lɛ wi lan bɔt di tin dɛn we kin apin ɛn di bad tin dɛn we kin apin to am.

Aw lɔng i kin tek fɔ si di rizɔlt?

Amvuttra na mɛrɛsin we de wok as tɛm de go. So, dɛn nɔ kin si di tin dɛn we kin apin wantɛm wantɛm. E kin tek sɔm mɔnt ɔr mɔr fɔ si ɛni impɔtant improvement pan di sayn dɛm.

Aw fɔ kɔntrol di bad tin dɛn we kin apin to pɔsin?

Wan pan di men sayd ɛfɛkt dɛm fɔ Amvuttra na we di vaytamɛn A lɛvɛl na di blɔd de go dɔŋ. dis na biכs di TTR protin na in de transpכt vaytam in A tru di bכdi. we di dכg de ridyus TTR prodakshכn, di transpכt fכ vaytam in A de dכn bak.

  • Yu dɔktɔ go ɔda ɔltɛm fɔ mek dɛn du blɔd tɛst fɔ chɛk yu vaytamɛn A lɛvɛl. I rili impɔtant fɔ mek dɛn du dɛn tɛst ya di rayt tɛm.
  • Ad it dɛn we gɛt bɔku vaytamɛn A (e.g. karɔt, swit pata, spinach, eg, milk, rɛd bɛl pepa ) to yu it.
  • If yu notis ɛni chenj na yu yay (especially we yu nɔ de si fayn na nɛt), tɛl yu dɔktɔ wantɛm wantɛm.
  • Dipen pan yu vaytamɛn A lɛvɛl, yu dɔktɔ kin se yu fɔ tek wan vaytamɛn A sɔpɔtmɛnt.

Dis nɔto di wangren sayd ɛfɛkt dɛm fɔ Amvuttra. If yu gɛt ɛni ɔda sayn we de mɔna yu, mek shɔ se yu tɔk to yu dɔktɔ .

Mɛsej we dɛn kin kɛr go na os

  • ATTR-CM na wan at sik we nכ kin apin bכt siriכs we kin kכz bay we di protin dεm we dεn fold fayn fayn wan na di at.
  • Amvuttra na wan mɛrɛsin we dɛn kin yuz tide fɔ dis ɛn dɛn kin injɛkt am ɛvri tri mɔnt.
  • Dis drɔg de wok bay we i de ridyus di prodakshɔn fɔ di prɔtin we nɔ fayn na di liva.
  • Risach dɔn sho se dis kin mek pipul dɛn nɔ day, dɛn kin put dɛn na ɔspitul, ɛn i kin mek di wan dɛn we sik nɔ gɛt bɛtɛ layf.
  • Bikɔs dis kin mek yu nɔ gɛt bɛtɛ vaytamɛn A, i impɔtant fɔ mek yu kɔntinyu fɔ tɔk to yu dɔktɔ ɔltɛm ɛn du tɛst ɔltɛm.
  • Bifo yu bigin ɛni tritmɛnt, tek tɛm tɔk to yu dɔktɔ bɔt di gud ɛn bad tin dɛn.

ATTR-CM, Amvuttra, vutrisiran, at sik, amyloidosis, at fεil, TTR protin

Frequently Asked Questions (FAQ)

Aw fɔ kɔntrol di bad tin dɛn we kin apin to pɔsin?

Wan pan di men sayd ɛfɛkt dɛm fɔ Amvuttra na we di vaytamɛn A lɛvɛl na di blɔd de go dɔŋ. dis na biכs di TTR protin na in de transpכt vaytam in A tru di bכdi. we di dכg de ridyus TTR prodakshכn, di transpכt fכ vaytam in A de dכn bak.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 3 + 9 =
Wi go tɔk bɔt di Amvuttra mɛrɛsin fɔ di at sik we dɛn kɔl ATTR-CM? (ATTR-CM & Amvuttra) ɛn di ɔda wan dɛn.

Wi go tɔk bɔt di Amvuttra mɛrɛsin fɔ di at sik we dɛn kɔl ATTR-CM? (ATTR-CM & Amvuttra) ɛn di ɔda wan dɛn.

Yu nɔr dɔn yɛri bɔt sik dɛm wae kin kam wae wan kayn prɔtin na wi bɔdi nɔr kin gɛda kɔrɛkt wan ɛn kin de na impɔtant ɔgan dɛm lɛk di at ɛn di nerv dɛm. Bɔku tɛm, dɛn sik ya na sik dɛn we nɔ kin apin so ɔltɛm. Insay mɛrɛsin, dɛn kɔl dis kayn prɔtin we de na di bɔdi amyloidosis . Tide, wi go tɔk bɔt wan sik we nɔ kin bɔku we dɛn kɔl ATTR-CM, we kin afɛkt di at spɛshal wan, dat na we dɛn prɔtin ya kin de na di at mɔsul, ɛn di mɔdan drɔg we dɛn kɔl Amvuttra we dɛn kin yuz fɔ am.

Wetin na ATTR-CM rili?

fכ simpul wan, ATTR-CM na kכndyushכn we, bikoz fכ wan jεnεtik difεkt כ we de apin nכmal wan wit ol pipul dεm, di protin TTR we de prodyuz na wi bכdi, de chenj shep εn kכlכm tכgeda εn deposit insεf na di wכl dεm na di at mכsul. Di ful nem fɔ dis na Transthyretin Amyloid Cardiomyopathy.

Tink bɔt am, wi at wɔl dɛn nid fɔ fleksibul fɔ pɔmp fayn fayn wan. Bɔt we dɛn prɔtin ya kin bɔku, di wɔl dɛn na di at kin tik ɛn stif . Wi kin kɔl dis kadiomayopathy. Dis kin mek di at nɔ ebul fɔ pɔmp blɔd fayn fayn wan. As tɛm de go, dis kin ivin go bifo te i nɔ de wok fayn.

Sɔm pipul dɛm wae gɛt ATTR-CM nɔr kin gɛt ɛni sayn, bɔt ɔda pipul dɛm kin gɛt sayn dɛm wae fiba di wan dɛm wae gɛt nɔrmal at atak.

  • Smɔl shɔt brith (dyspnea) .
  • Swel, mɔ na di leg ɛn anklɛ
  • Kɔnfyushɔn ɔ pwɛl at
  • At rit we de go ɔp ɔ at bit we nɔ de bit ɔltɛm
  • Chɛst de pen

Dis kin mek yu fil taya kwik kwik wan we yu de du tin lɛk fɔ klaym stej, fɔ du os wok, ɔ fɔ waka fɔ shɔt tɛm.

Apat frɔm dat, ɔda sayn dɛn we nɔ gɛt natin fɔ du wit di at kin apin bak. Fɔ ɛgzampul, wikɛd, swɛt ɔ pen na yu an ɛn fut, yu de swet pasmak , yu ed de tɔn ɔ yu fɔdɔm, ɛn yu gɛt prɔblɛm wit yu digest.

Aw Amvuttra mɛrɛsin de wok?

fכ כndastand dis, wi fכs nid fכ no sכm bכt wan protin we dεn kכl TTR. TTR (Transthyretin) na wan prɔtin we dɛn kin mek mɔ na wi liva. di men wok we i de du na fכ transpot di tayroyd כmon dεm εn vaytam in A כlsay na di bכdi.

pan pipul dεm we gεt ATTR-CM, wan jεnεtik difεkt de mek di TTR protin de prodyuz in kכrekt shep. dis kכrekt shep fכ di protin de kכmכt εn dכn na di at.

Di drɔg we dɛn kɔl Amvuttra de wok lɛk jin saylɛns . dat min se dis dכg de go stret na di liva εn i de blכk da fכlt TTR protin de.i de ridyus di aktiviti fכ di jin we dεn de mek. I tan lɛk we yu de tɔn di vɔlyum dɔŋ na redio.

dis de ridyus di fכlt TTR protin we di liva de prodyuz, we in tכn de ridyus di dכpos fכ nyu protin dεm na כgan dεm lεk di at.

Amvuttra na injɛkshɔn we dɛn kin put ɔnda di bɔdi. Dis vaysin na pɔsin we sabi kia fɔ wɛlbɔdi biznɛs kin gi am ɛvri tri mɔnt .

Aw dɛn bin tɛst di sakrifays we dis mɛrɛsin bin gɛt?

Lɛk ɛni nyu mɛrɛsin, dɛn dɔn kɔnfyus di ɛfɛktiv we AMVUTTRA de du tru wan big stɔdi. Insay dis stɔdi, dɛn gi 655 ATTR-CM pasɛnt dɛn di Amvuttra vaysin ɛn di ɔda grup dɛn gi wan plesibo vaysin we nɔ gɛt ɛni drɔg ɛvri 12 mɔnt fɔ tri ia.

Risach pipul dɛn bin luk bɔku tin dɛn fɔ no if dis mɛrɛsin de wok.

  • Siks minit waka tɛst: Dis de mɛzhɔ aw fa yu kin waka wit nɔmal paz insay 6 minit. Dis distans de go dɔŋ as yu at de wɔs.
  • Nyu Yɔk At Asɛmbli (NYHA) klasification: Dis de mɛzhɔ aw di sayn dɛm wae de sho se pɔrsin gɛt at pwɛl. Fo klas de (I, II, III, IV). Di mɔ di klas nɔmba de bɔku, na di mɔ di sik kin rili bad.
NYHA Klas Tɔk bɔt
Klas I No ristrikshɔn nɔ de fɔ di nɔmal tin dɛn we pɔsin kin du fɔ du in bɔdi. Nɔ taya, nɔ de blo shɔt, ɔ pen na in chɛst.
Klas II Di tin dɛn we pɔsin kin du fɔ du bɔdi wok nɔ kin izi fɔ du. Nɔbɔdi nɔ kin fil bad we yu de rɛst, bɔt yu kin taya ɛn taya we yu de du tin dɛn we yu de du nɔmal tin.
Klas IIIdi fyzikal aktiviti dεm nכ kin bכku, εn di sayn dεm kin apin ivin we i de wok tranga pas di nכmal wok.
Klas IV Di sayn dɛm kin de ivin we yu rɛst. Ɛnitin we yu de du fɔ yu bɔdi kin mek di sik wɔs.
  • Kwaliti ɔf Layf Kwɛshɔn (KCCQ-OS): Dis de mɛzhɔ di impak we di sik gɛt pan di pɔsin in kwaliti layf.

Wetin di risach bin fɛn?

We di tri ia tritmɛnt tɛm dɔn, di wan dɛn we du di risach bin analayz di rizɔlt dɛn.

Di men tin we dɛn fɛn na dat di pasɛnt dɛn we bin gɛt Amvuttra bin gɛt 28% lɔwa risk fɔ day ɔ fɔ go na ɔspitul wantɛm wantɛm ɔ fɔ go na di imejensi rum (ETU) bikɔs dɛn at pwɛl , we yu kɔmpia dɛn wit di wan dɛn we bin gɛt plasɛbo (wan dɔmi vaysin).

Wan ɔda impɔtant tin na dat we 42 mɔnt dɔn, di risk fɔ day frɔm ɛni kɔz bin ridyus bay 35% na di grup we bin gɛt Amvuttra.

Apat frɔm dat, di pasɛnt dɛn we bin gɛt Amvuttra bin gɛt wan kɔntrol dɛklin pan di ebul fɔ waka ɛn di kwaliti fɔ layf.

Bɔt mɛmba se dɛn risach ya nɔ go bi di sem fɔ ɔlman. Yu ɛn yu dɔktɔ go nid fɔ disayd togɛda if Amvuttra rayt fɔ yu ɛn if di bɛnifit dɛn pas di sayd ɛfɛkt dɛn.

Lɛ wi lan bɔt di tin dɛn we kin apin ɛn di bad tin dɛn we kin apin to am.

Aw lɔng i kin tek fɔ si di rizɔlt?

Amvuttra na mɛrɛsin we de wok as tɛm de go. So, dɛn nɔ kin si di tin dɛn we kin apin wantɛm wantɛm. E kin tek sɔm mɔnt ɔr mɔr fɔ si ɛni impɔtant improvement pan di sayn dɛm.

Aw fɔ kɔntrol di bad tin dɛn we kin apin to pɔsin?

Wan pan di men sayd ɛfɛkt dɛm fɔ Amvuttra na we di vaytamɛn A lɛvɛl na di blɔd de go dɔŋ. dis na biכs di TTR protin na in de transpכt vaytam in A tru di bכdi. we di dכg de ridyus TTR prodakshכn, di transpכt fכ vaytam in A de dכn bak.

  • Yu dɔktɔ go ɔda ɔltɛm fɔ mek dɛn du blɔd tɛst fɔ chɛk yu vaytamɛn A lɛvɛl. I rili impɔtant fɔ mek dɛn du dɛn tɛst ya di rayt tɛm.
  • Ad it dɛn we gɛt bɔku vaytamɛn A (e.g. karɔt, swit pata, spinach, eg, milk, rɛd bɛl pepa ) to yu it.
  • If yu notis ɛni chenj na yu yay (especially we yu nɔ de si fayn na nɛt), tɛl yu dɔktɔ wantɛm wantɛm.
  • Dipen pan yu vaytamɛn A lɛvɛl, yu dɔktɔ kin se yu fɔ tek wan vaytamɛn A sɔpɔtmɛnt.

Dis nɔto di wangren sayd ɛfɛkt dɛm fɔ Amvuttra. If yu gɛt ɛni ɔda sayn we de mɔna yu, mek shɔ se yu tɔk to yu dɔktɔ .

Mɛsej we dɛn kin kɛr go na os

  • ATTR-CM na wan at sik we nכ kin apin bכt siriכs we kin kכz bay we di protin dεm we dεn fold fayn fayn wan na di at.
  • Amvuttra na wan mɛrɛsin we dɛn kin yuz tide fɔ dis ɛn dɛn kin injɛkt am ɛvri tri mɔnt.
  • Dis drɔg de wok bay we i de ridyus di prodakshɔn fɔ di prɔtin we nɔ fayn na di liva.
  • Risach dɔn sho se dis kin mek pipul dɛn nɔ day, dɛn kin put dɛn na ɔspitul, ɛn i kin mek di wan dɛn we sik nɔ gɛt bɛtɛ layf.
  • Bikɔs dis kin mek yu nɔ gɛt bɛtɛ vaytamɛn A, i impɔtant fɔ mek yu kɔntinyu fɔ tɔk to yu dɔktɔ ɔltɛm ɛn du tɛst ɔltɛm.
  • Bifo yu bigin ɛni tritmɛnt, tek tɛm tɔk to yu dɔktɔ bɔt di gud ɛn bad tin dɛn.

ATTR-CM, Amvuttra, vutrisiran, at sik, amyloidosis, at fεil, TTR protin

Frequently Asked Questions (FAQ)

Aw fɔ kɔntrol di bad tin dɛn we kin apin to pɔsin?

Wan pan di men sayd ɛfɛkt dɛm fɔ Amvuttra na we di vaytamɛn A lɛvɛl na di blɔd de go dɔŋ. dis na biכs di TTR protin na in de transpכt vaytam in A tru di bכdi. we di dכg de ridyus TTR prodakshכn, di transpכt fכ vaytam in A de dכn bak.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 3 + 9 =